JEREMY WALKER: Open Payments
NPI 1164970570 · CLAY, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,268 in 75 payments from 15 companies in 2025. Trend: 2023 $567 · 2024 $1,082 · 2025 $1,268
Food & beverage: $1,268
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $333 |
| ABBVIE INC. | 16 | $217 |
| Novartis Pharmaceuticals Corporation | 8 | $151 |
| AstraZeneca Pharmaceuticals LP | 7 | $145 |
| Amgen Inc. | 5 | $98 |
| Sumitomo Pharma America, Inc. | 4 | $84 |
| Phathom Pharmaceuticals, Inc. | 4 | $41 |
| Dexcom, Inc. | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
Products named: UBRELVY, LEQVIO, Rybelsus, Ozempic, EVENITY, AIRSUPRA, GEMTESA, FARXIGA.
Industry payments across WV — which companies pay providers there.
